Bratton Capital Management, L.P., 10% Owner at Denali Therapeutics Inc. (DNLI), sold 499,800 shares at $24.01 ($12.0M) on 2020-06-30, disclosed to the SEC on 2020-06-30.
Open-market sale of $12.0M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.84 | 108,473 | $2.6M | 21.6% |
| 2 | $23.84 | 108,473 | $2.6M | 21.6% |
| 3 | $24.67 | 13,604 | $336K | 2.8% |
| 4 | $24.67 | 13,604 | $336K | 2.8% |
| 5 | $23.84 | 61,807 | $1.5M | 12.3% |
| 6 | $23.84 | 61,807 |
| $1.5M |
| 12.3% |
| 7 | $24.50 | 20,771 | $509K | 4.2% |
| 8 | $24.50 | 20,771 | $509K | 4.2% |
| 9 | $24.01 | 45,145 | $1.1M | 9.0% |
| 10 | $24.01 | 45,145 | $1.1M | 9.0% |
| 11 | $24.34 | 200 | $5K | 0.0% |
| Total | $23.97 avg | 499,800 | $12.0M | 100% |